Sativex achieved sustained
improvements in spasticity vs
placebo when used as an adjunct1

Response rates
Image
graph

Up to 71%
of patients
responded
to 4 weeks’
treatment with
Sativex*1–4

The response rates achieved in practice were at least as good as those seen in clinical trials*1–4

Image
graph-mobile
Image
graph-mobile

Learn about the 4-week trial period and GW Pharmaceuticals’
pay-for-responders scheme